From record-breaking litigation wins to billion-dollar deals and global policy leadership, this year’s cohort features the ...

WilmerHale trade secrets expert moves to new firm ...

UPC revives patent, but timing sinks Guardant’s appeal ...

A new report warns that sweeping procurement reforms in Mainland China, alongside open robotics platforms, supply chain disruption and GLP-1 drugs, are changing competition and challenging ...

HGF expands European offering with pair of in-house hires ...

A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over ...

A first-chair trial lawyer with two decades in high-stakes patent and trade secret disputes brings experience across medical devices, biologics, and pharmaceuticals, alongside a broader ...

Otsuka v Sun Pharma could redefine which pharmaceutical patents qualify for patent term extensions, with major implications ...